| 211 | Casale, T. B., Bernstein, J. A., Maurer, M. Saini, S. S., Trzaskoma, B., Chen, H., Grattan, C., Gimenèz-Arnau, A., Kaplan, A. P., and Rosén, K.+: Similar efficacy with Omalizumab in chronic idiopathic/spontaneous urticaria despite different background therapy. J. Allergy Clin. Immunol. Pract. 2015: 3; 743-750. IF: 5.42 |
| 118. | Beck, L. A., Bernstein, J. A., and Maurer, M.: A review of international recommendations for the diagnosis and management of chronic urticaria. Acta Derm. Venereol. 2017: 97; 149-158. IF: 3.13 |
r.118
This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Devel- opment and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-founded
| 310 | Zuberbier, T.+, Aberer, W., Asero, R., Abdul Latiff, A. H., Baker, D., Ballmer-Weber, B., Bernstein, J. A., Bindslev-Jensen, C., Brzoza, Z., Buense Bedrikow, R., Canonica, G. W., Church, M. K., Craig, T., Danilycheva, I. V., Dressler, C., Ensina, L. F., Giménez-Arnau, A., Godse, K., Goncalo, M., Grattan, C., Hebert, J., Hide, M., Kaplan, A., Kapp, A., Katelaris, C. H., Kocatürk, E., Kulthanan, K., Larenas-Linnemann, D., Leslie, T. A., Magerl, M., Mathelier-Fusade, P., Meshkova, R. Y., Metz, M., Nast, A., Nettis, E., Oude-Elberink, H., Rosumeck, S., Saini, S. S., Sánchez-Borges, M., Schmid-Grendelmeier, P., Staubach, P., Sussman, G., Toubi, E., Vena, G. A., Vestergaard, C., Wedi, B., Werner, R. N., Zhao, Z., and Maurer, M.: The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. The 2017 revision and update. Allergy 2018: 73; 1393-1414. IF: 6.77 |
| 185 | Zuberbier, T.+, Aberer, W., Asero, R., Bindslev-Jensen, C. Brzoza, Z., Canonica, G. W., Church, M. K., Ensina, L. F., Giménez-Arnau, A., Godse, K., Goncalo, M., Grattan, C., Hebert, J., Hide, M., Kaplan, A., Kapp, A., Abdul Latiff, A. H., Mathelier-Fusade, P., Metz, M., Saini, S. S., Sánchez-Borges, M., Schmid-Grendelmeier P., Simons, F. E., Staubach, P., Sussman, G., Toubi, E., Vena, G. A., Wedi, B., Zhu, X. J., Nast, A., and Maurer, M.: Methods report on the development of the 2013 revision and update of the EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2014: 69; e1-e29. IF: 6.03 |
o.185
| 184 | Zuberbier, T.+, Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z., Canonica, G. W., Church, M. K., Ensina, L. F., Giménez-Arnau, A., Godse, K., Goncalo, M., Grattan, C., Hebert, J., Hide, M., Kaplan, A., Kapp, A., Abdul Latiff, A. H., Mathelier-Fusade, P., Metz, M., Nast, A., Saini, S. S., Sánches-Borges, M., Schmidt-Grendelmeier, P., Simons, F. E. R., Staubach, P., Sussman, G., Toubi, E., Vena, G. A., Wedi, B., Zhu, X. J., and Maurer, M.: The EAACI/GA²LEN/EDF/WAO Guideline for the definition, classification, diagnosis and management of Urticaria. The 2013 revision and update. Allergy 2014: 69; 868-887. IF: 6.03 |
| 163 | Kaplan, A., Ledford, D., Ashby, M., Canvin, J, Zazzali, J. L., Conner, E., Veith, J., Kamath, N., Staubach, P., Jakob, T., Stirling, R. G., Kuna, P., Berger, W., Maurer, M. and Rosén, K.+: Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J. Allergy Clin. Immunol. 2013: 132; 101-109. IF: 11.25 |
| 138 | Zuberbier, T.+, Aberer, W., Brockow, K., Grabbe, J., Hamelmann, E., Hartmann, K., Jakob, T., Maurer, M. Merk, H. F., Ollert, M., Ruëff, F., Schmid-Grendelmeier, P., Staubach, P., Voigtmann, I., and Wedi, B.: Therapy of urticaria: German language version of the international S3-guideline. Allergologie 2012: 4; 187-208. IF 0.33 |
Therapy of urticaria: German language version of the international S3-guideline Read More »